These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32222333)

  • 1. Don't forget Arnhem!
    van der Steen-Banasik EM; Oosterveld BJ; Smits GA
    Radiother Oncol; 2020 Jun; 147():236. PubMed ID: 32222333
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' response to Letter to the Editor "Don't forget Arnhem".
    Voskuilen CS; Bosschieter J; Nieuwenhuijzen JA; van Rhijn BWG
    Radiother Oncol; 2020 Jun; 147():237. PubMed ID: 32223940
    [No Abstract]   [Full Text] [Related]  

  • 3. Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study.
    van der Steen-Banasik E; Ploeg M; Witjes JA; van Rey FS; Idema JG; Heijbroek RP; Karthaus HF; Reinders JG; Viddeleer A; Visser AG
    Radiother Oncol; 2009 Nov; 93(2):352-7. PubMed ID: 19457565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Curie-Da Vinci Connection: 5-Years' Experience With Laparoscopic (Robot-Assisted) Implantation for High-Dose-Rate Brachytherapy of Solitary T2 Bladder Tumors.
    van der Steen-Banasik EM; Smits GAHJ; Oosterveld BJ; Janssen T; Visser AG
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1439-1442. PubMed ID: 27296041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saving bladders with brachytherapy: implantation technique and results.
    Van der Steen-Banasik EM; Visser AG; Reinders JG; Heijbroek RP; Idema JG; Janssen TG; Leer JW
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):622-9. PubMed ID: 12062605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer treatment: optimize, don't compromise.
    Bochner BH; Laudone VP
    Oncology (Williston Park); 2011 Dec; 25(14):1412-3. PubMed ID: 22329193
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimodal Therapy for Bladder Cancer: You Get What You Don't Pay For.
    Cole AP; Trinh QD
    JAMA Surg; 2019 Aug; 154(8):e191637. PubMed ID: 31166585
    [No Abstract]   [Full Text] [Related]  

  • 8. GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
    Pieters BR; van der Steen-Banasik E; Smits GA; De Brabandere M; Bossi A; Van Limbergen E
    Radiother Oncol; 2017 Mar; 122(3):340-346. PubMed ID: 28049550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brachytherapy for urinary bladder cancer].
    González González D; Haitze van der Veen J; Ypma AF; Blank LE; Hoestra CJ; Veen RE
    Arch Esp Urol; 1999; 52(6):655-61. PubMed ID: 10484849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign postoperative spindle cell nodule of the urinary bladder? don't think so.
    Heffner DK
    Ann Diagn Pathol; 2004 Apr; 8(2):108-14. PubMed ID: 15060890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Don't Bet Against the Elderly.
    Hamstra DA
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):7. PubMed ID: 28816163
    [No Abstract]   [Full Text] [Related]  

  • 12. Brachytherapy in the treatment of invasive bladder cancer.
    Pos F; Moonen L
    Semin Radiat Oncol; 2005 Jan; 15(1):49-54. PubMed ID: 15662607
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
    Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Curietherapy of cancer of the bladder].
    COSTA LP
    Rev Argent Urol; 1955; 24(4-6):236-9. PubMed ID: 13267073
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy.
    Raleigh DR; Hsu IC; Braunstein S; Chang AJ; Simko JP; Roach M
    Brachytherapy; 2015; 14(2):185-8. PubMed ID: 25533416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
    de Crevoisier R; Ammor A; Court B; Wibault P; Chirat E; Fizazi K; Theodore C; Yom SS; Haie-Meder C
    Radiother Oncol; 2004 Aug; 72(2):147-57. PubMed ID: 15376367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatraemic renal pseudofailure--don't forget the possibility of uroperitoneum.
    Wystrychowski A; Nowicki M; Kokot F
    Nephrol Dial Transplant; 1996 Dec; 11(12):2491-2. PubMed ID: 9017630
    [No Abstract]   [Full Text] [Related]  

  • 18. T1G3 bladder cancer and Bacillus Calmette-Guérin: tell me something we don't know.
    Yates DR
    Eur Urol; 2015 Jan; 67(1):83-84. PubMed ID: 25109573
    [No Abstract]   [Full Text] [Related]  

  • 19. The Role of Reconstructive Surgery and Brachytherapy in Pediatric Bladder/Prostate Rhabdomyosarcoma.
    Schmidt A; Warmann SW; Eckert F; Ellerkamp V; Schaefer J; Blumenstock G; Paulsen F; Fuchs J
    J Urol; 2020 Oct; 204(4):825-834. PubMed ID: 32379564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.